Clinical Trials Browser

Completed × Hemangiosarcoma × pazopanib × Clear all

Hemangiosarcoma, Sarcoma

NCT01532687 2021-09-27

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

NCT01975519 2020-05-20

A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

Phase 1/2 Completed

111 enrolled 15 charts

Sarcoma

Hemangiosarcoma, Sarcoma

NCT02979899 2020-05-12

TAPPAS

Phase 3 Completed

128 enrolled 13 charts

Sarcoma

Hemangiosarcoma

Clinical Trials

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

TAPPAS